SCHEMBL7861589

SCHEMBL7861589

Fc1ccc(Cn2c(N[C@H]3CCN[C@H](Cc4ccccc4)C3)nc3ccccc32)cc1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 6/20 0.70
NR4A2 P43354 2/20 0.70
SSTR5 P35346 8/20 0.65
HRH1 P35367 5/20 0.51
CHRM1 P11229 3/20 0.51
EED O75530 2/20 0.51
LMNA P02545 2/20 0.51
GAA P10253 2/20 0.51
HRH4 Q9H3N8 2/20 0.51
CYP2D6 P10635 2/20 0.51
HTR3A P46098 2/20 0.51
MEN1 O00255 1/20 0.51
MLNR O43193 1/20 0.51
CACNA1F O60840 1/20 0.51
USP2 O75604 1/20 0.51
ABCB11 O95342 1/20 0.51
EGFR P00533 1/20 0.51
HLA-A P04439 1/20 0.51
ERBB2 P04626 1/20 0.51
TP53 P04637 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7861587 1.00 KCNH2 (0.70) KCNH2NR4A2SSTR5HRH1CHRM1
SCHEMBL7865206 0.84 KCNH2 (0.48) KCNH2NR4A2SSTR5HRH1CHRM1
SCHEMBL7865204 0.84 KCNH2 (0.48) KCNH2NR4A2SSTR5HRH1CHRM1
SCHEMBL7860380 0.83 KCNH2 (0.48) KCNH2NR4A2SSTR5MAPTHTT
SCHEMBL7860383 0.83 KCNH2 (0.48) KCNH2NR4A2SSTR5MAPTHTT
Tecastemizole SCHEMBL18200 0.83 KCNH2 (1.00) KCNH2NR4A2SSTR5HRH1CHRM1
SCHEMBL7860295 0.82 KCNH2 (0.43) KCNH2NR4A2SSTR5LMNAKMT2A
SCHEMBL7860293 0.82 KCNH2 (0.43) KCNH2NR4A2SSTR5LMNAKMT2A
Tecastemizole SCHEMBL9698437 0.82 KCNH2 (0.98) KCNH2NR4A2SSTR5HRH1CHRM1
Tecastemizole SCHEMBL11278980 0.82 KCNH2 (0.98) KCNH2NR4A2SSTR5HRH1CHRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0869955-B1 N-ACYL-2-SUBSTITUTED-4-(BENZIMIDAZOLYL- OR IMIDAZOPYRIDINYL-SUBSTITUTED RESIDUES)-PIPERIDINES AS TACHYKININ ANTAGONISTS JANSSEN PHARMACEUTICA NV (BE) 2001-10-24 EP disclosed
US-6110939-A AS A SUBSTANCE P ANTAGONISTS TREATING TACHYKININ-MEDIATED DISEASE, ASTHMA, CENTRAL NERVOUS SYSTEM DISORDER JANSSEN PHARMACEUTICA N.V. (BE) 2000-08-29 US disclosed